Epernicus: Irene Winicov, Ph.D.

Irene Winicov, Ph.D.

Position:
Lab Director

Redox Pharmaceutical Corp
Degrees:

Ph.D., Biochemistry, City University of New York (New York, NY)
Past Advisors:
Research:

Communities:

Irene Winicov's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.

Irene Winicov's Publications (6)

Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model.
Epstein SP, Pashinsky YY, Gershon D, Winicov I, Srivilasa C, Kristic KJ, Asbell PA

BMC ophthalmology. 2006;6:22
Protein synthesis during acquisition of long-term facilitation is needed for the persistent loss of regulatory subunits of the Aplysia cAMP-dependent protein kinase.
Bergold PJ, Sweatt JD, Winicov I, Weiss KR, Kandel ER, Schwartz JH

Proceedings of the National Academy of Sciences of the United States of America. 1990 May;87(10):3788-91
Sphingosine interacts directly with the receptor complex to inhibit thyrotropin-releasing hormone binding.
Winicov I, Cory RN, Gershengorn MC

Endocrinology. 1990 Mar;126(3):1668-72
Receptor density determines secretory response patterns mediate by inositol lipid-derived second messengers. Comparison of thyrotropin-releasing hormone and carbamylcholine actions in thyroid-stimulating hormone-secreting mouse pituitary tumor cells.
Winicov I, Gershengorn MC

The Journal of biological chemistry. 1989 Jun 5;264(16):9438-43
Transient permeabilization of endocrine cells: inositol lipid metabolism.
Winicov I, Gershengorn MC

Methods in enzymology. 1989;168:218-25
Sphingosine inhibits thyrotropin-releasing hormone binding to pituitary cells by a mechanism independent of protein kinase C.
Winicov I, Gershengorn MC

The Journal of biological chemistry. 1988 Sep 5;263(25):12179-82

Join Epernicus (membership is free)

Epernicus is open to current and former research scientists.

Already a member?
Sign in to view Irene's full profile.